Abstract:Lappaconitine instead of its hydrobromide salts has been encapsulated in poly (lactide-co-glycolide) acid (PLGA) microspheres by the simple o/w emulsion solvent evaporation technique. The effects of several variables including emulsifier (polyvinyl alcohol, PVA) concentration, stirring speed, PLGA concentration and drug/polymer mass ratios on quality of microspheres have been investigated. The particle size and size distribution can be controlled by PVA concentration, stirring speed and PLGA concentration. The entrapment efficiency and the burst release of lappaconitine from drug-loaded microspheres were dominantly affected by the drug/polymer mass ratio and PVA concentration. The best parameters of formulation were 1.5% PVA, the PLGA concentration of 50 g/L, and the stirring speed of 800 rpm and drug/polymer of 1:5. The optimized formulation has a mean particle size of 19.3+/-0.93 mu M, mean entrapment efficiency of 70.77+/-3.23% and mean drug loading of 11.45+/-0.47%. Based on the optimized parameters of formulation, the effects of oil/aqueous solubility partition ratio of drug on entrapment efficiency of drug-loaded microspheres prepared by o/w emulsion solvent evaporation were further studied. A good linear relation existed between the partition ratio and entrapment efficiency. The optimized microspheres were characterized by SEM, FT-IR, DSC and XRD. SEM shows spherical and smooth surface and uniform size distribution. The results of DSC, FT-IR study reveal no interaction between drug and polymer. The results of the XRD study indicate lappaconitine trapped in microsphere exists in form of an amorphous or disordered crystalline status in polymer matrix. The in vitro release models were evaluated with two different groups of drug-loaded microspheres including microspheres washed with distilled water and 0.01N HCL, respectively. The drug release profile of lappaconitine-loaded microspheres washed with distilled water agreed with zero order equation and that of the latter better agreed with first order equation.

Preparation of Lappaconitine Hydrobromide Dispersible Tablets and the Study of Its Dis-solution Characteristics in Vitro

Preparation and Quality Control of Levamlodipine Besylate Orally Disintegrating Tablets

Studies on Pulsatile-Release Tablets of Lappaconitine Hydrobromide

Study on formulation of ibuprofen dispersible tablets

Study on the Preparation Technique of Tanshinone Dispersible Tablets

Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.

[Preparation and Quality Evaluation of Fufangxiaoyepipa Dispersible Tablets].

Hydrophilic Matrix Sustained Release Tablets of Lappaconite Hydrobromide:Preparation and Release in Vitro

Formulation Optimization and the in Vitro Release Characteristics of Fuyankang Dispersible Tablets

Preparation of Nystatin Dispersible Tablets

Optimization of the Preparation of Lamiophlomis Rotata Dispersible Tablets Using Central Composite Design

Preparation of lappaconitine hydrobromide transdermal microemulsions and evaluation of transdermal delivery

Preparation Process of Dispersible Tablets of Liuweidihuang

Study on Prescription of Crataegi Folium Flavonoids Dispersible Tablets

Preparation of Fufang Shuanghuanglian Dispersible Tablets

Preparation of Ibuprofen and Diphenhydramine Hydrochloride Dispersible Tablets and Their Quality Evaluation

Preparation and Quality Investigation of Nateglinide Dispersible Tablets

Comparative Studies of the in Vitro Dissolution and in Vivo Pharmacokinetics for Different Formulation Strategies (solid Dispersion, Micronization, and Nanocrystals) for Poorly Water-Soluble Drugs: A Case Study for Lacidipine

Study on Formulation of Dispersible Tablets of Shuanghuanglian

Study on the Formulation Optimization and Dissolution of Yinzhihuang Dispersible Tablets